Citadel Advisors - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 105 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$166,291
+18.9%
34,789
+5.7%
0.00%
Q2 2023$139,914
-91.4%
32,921
-89.3%
0.00%
Q1 2023$1,635,215
+328.3%
307,950
+406.5%
0.00%
Q4 2022$381,793
-65.4%
60,795
-41.9%
0.00%
Q3 2022$1,104,000
+10.3%
104,631
-43.3%
0.00%
Q2 2022$1,001,000
-73.3%
184,475
-54.8%
0.00%
-100.0%
Q1 2022$3,744,000
+40.8%
407,801
+131.3%
0.00%
Q4 2021$2,660,000176,3100.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders